Schering-Plough (SGP) CEO Hassan Buys $2M Worth of Stock
More News related to SGP
- Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
- Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings
- SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
Schering-Plough Corp. (NYSE: SGP) today announced that its Chairman and CEO, Fred Hassan, bought over $2 million of Schering-Plough common stock, or 110, 000 shares at an average purchase price of $18.26 per share.
Hassan said, "As I said when I announced my intention to purchase these shares in January, this investment in Schering-Plough reflects my long-term confidence in the company, its products -- including ZETIA and VYTORIN -- and our late- stage pipeline."
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. [BCS]
Related Categories
Hot ListInsider Trades
Stocks Mentioned
+2.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
